Sertraline
- Generic Name
- Sertraline
- Brand Names
- Zoloft
- Drug Type
- Small Molecule
- Chemical Formula
- C17H17Cl2N
- CAS Number
- 79617-96-2
- Unique Ingredient Identifier
- QUC7NX6WMB
- Background
Sertraline is a popular antidepressant medication commonly known as a selective serotonin reuptake inhibitor (SSRI), and is similar to drugs such as Citalopram and Fluoxetine. Despite marked structural differences between compounds in this drug class, SSRIs exert similar pharmacological effects.
...
- Indication
Sertraline is indicated for the management of major depressive disorder (MDD), post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), panic disorder (PD), premenstrual dysphoric disorder (PMDD), and social anxiety disorder (SAD). Common off-label uses for sertraline include the prevention of post stroke depression, generalized anxiety di...
- Associated Conditions
- Binge Eating Disorder (BED), Bulimia Nervosa, Generalized Anxiety Disorder, Major Depressive Disorder (MDD), Obsessive Compulsive Disorder (OCD), Panic Disorder, Post Traumatic Stress Disorder (PTSD), Premenstrual Dysphoric Disorder (PMDD), Social Anxiety Disorder (SAD)
- Associated Therapies
- -
Depression Care Management for Depressed Elders in China Primary Care
- First Posted Date
- 2011-02-01
- Last Posted Date
- 2011-02-01
- Lead Sponsor
- Zhejiang University
- Target Recruit Count
- 320
- Registration Number
- NCT01287494
- Locations
- 🇨🇳
Zhejiang Univeristy, Hangzhou, Zhejiang, China
Bioequivalence Study of Sertraline Hydrochloride Tablets 100 mg Under Fasting Conditions
- First Posted Date
- 2010-12-28
- Last Posted Date
- 2012-01-11
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 32
- Registration Number
- NCT01267396
- Locations
- 🇮🇳
Veeda Clinical Research (P) Ltd, Ambawadi, Ahmedabad, India
Bioequivalence Study of Sertraline Hydrochloride Tablets 100 mg in Fed Conditions
- First Posted Date
- 2010-12-28
- Last Posted Date
- 2012-01-11
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 32
- Registration Number
- NCT01267383
- Locations
- 🇮🇳
Veeda Clinical Research (P) Ltd, Ambawadi, Ahmedabad, India
A Pharmacokinetic Study of the Coadministration of LY2216684 With Sertraline
- First Posted Date
- 2010-12-01
- Last Posted Date
- 2019-01-04
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 20
- Registration Number
- NCT01250873
- Locations
- 🇺🇸
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Daytona Beach, Florida, United States
Pharmacokinetic Properties of Sertraline Before and After Gastric Bypass Surgery
- First Posted Date
- 2010-10-05
- Last Posted Date
- 2016-04-06
- Lead Sponsor
- North Dakota State University
- Target Recruit Count
- 31
- Registration Number
- NCT01214382
- Locations
- 🇺🇸
Neuropsychiatric Research Institute, Fargo, North Dakota, United States
Combined Mirtazapine and SSRI Treatment of PTSD: A Placebo-Controlled Trial
- Conditions
- Interventions
- First Posted Date
- 2010-08-10
- Last Posted Date
- 2016-04-08
- Lead Sponsor
- Research Foundation for Mental Hygiene, Inc.
- Target Recruit Count
- 38
- Registration Number
- NCT01178671
- Locations
- 🇺🇸
Anxiety Disorders Clinic, New York State Psychiatric Institute, New York, New York, United States
Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and Adolescents
- Conditions
- Interventions
- First Posted Date
- 2010-07-12
- Last Posted Date
- 2015-05-27
- Lead Sponsor
- University of Michigan
- Target Recruit Count
- 156
- Registration Number
- NCT01160588
- Locations
- 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
The Effects of Treatment With Sertraline for Noncardiac Chest Pain
- Conditions
- Interventions
- First Posted Date
- 2010-04-30
- Last Posted Date
- 2010-05-18
- Lead Sponsor
- Maastricht University Medical Center
- Target Recruit Count
- 210
- Registration Number
- NCT01114100
- Locations
- 🇳🇱
Maastricht University Medical Centre, Maastricht, Netherlands
Strategic Use of New Generation Antidepressants for Depression
- Conditions
- Interventions
- First Posted Date
- 2010-04-23
- Last Posted Date
- 2016-10-03
- Lead Sponsor
- Kyoto University
- Target Recruit Count
- 2011
- Registration Number
- NCT01109693
- Locations
- 🇯🇵
Nagoya City University Hospital, Nagoya, Aichi, Japan
🇯🇵Kochi Medical School Hospital, Nangoku, Kochi, Japan
Rhodiola Rosea Therapy of Major Depressive Disorder
- Conditions
- Interventions
- First Posted Date
- 2010-04-02
- Last Posted Date
- 2018-02-22
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 58
- Registration Number
- NCT01098318
- Locations
- 🇺🇸
Depression Research Unit, Philadelphia, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.